(142 days)
Not Found
No
The description mentions "various algorithms" for image analysis, but there is no mention of AI, ML, deep learning, or any related concepts. The focus is on standard image processing and comparison to a normative database.
No
The device is indicated for estimating bone density to aid in determining fracture risk and monitoring changes in bone mass, but it does not treat or alleviate any condition.
Yes
Explanation: The device produces BMD estimates, t-scores, and z-scores which can be used by a physician as an aid to diagnose osteoporosis or osteopenia and other disorders affecting bone mass, and to estimate fracture risk, which are all diagnostic aid functions.
No
The device description explicitly states it is a Dual Energy X-ray Absorptiometer (DXA) screening device and describes hardware components like an X-ray tube, touchscreen LCD panel, and membrane switch/indicator panel.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD definition: In Vitro Diagnostics are medical devices intended for use in vitro for the examination of specimens, including blood, tissue, and urine, derived from the human body, solely or principally for the purpose of providing information concerning a physiological or pathological state, or a congenital abnormality, or to monitor therapeutic measures.
- Accudxa 2 function: The Accudxa 2 is a device that uses X-rays to directly measure bone density in a living person's finger. It does not analyze specimens taken from the body.
- Direct measurement: The device interacts directly with the patient's body to obtain the measurement.
Therefore, based on the provided information, the Accudxa 2 is a medical device but not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The Accudxa 2 is a dual-energy x-ray (DXA) device indicated for use in estimating the bone density of the middle finger of the non-dominant hand (BMD). This BMD value is a relative indicator of bone density elsewhere in the body. Accudxa 2 BMD estimates, t-score and z-score can be used as an aid to the physician in determining fracture risk and for monitoring changes in bone mass over time.
Product codes (comma separated list FDA assigned to the subject device)
KGI
Device Description
The Accudxa 2 Model 7200 is a Dual Energy X-ray Absorptiometer (DXA) screening device. The device is intended to calculate an index of bone mineral density in the middle finger of the non-dominant hand. By changing the high voltage on the X-ray tube, two energies are produced. Each of the two settings produces an image of the finger and each image is analyzed using various algorithms to produce a value of bone mineral density (BMD) and bone mineral content (BMC). These values are compared with a normative database, vielding a t-score and a z-score. The t-score is the number of standard deviations that the patient is above or below the mean of a reference sample of young healthy individuals, which can be used by the physician as an aid to diagnose osteoporosis or osteopenia and to estimate fracture risk. The z-score is the number of standard deviations that the patient is above or below the mean of a reference sample of individuals of the same age as the patient, which can be used by the physician as an aid to diagnose other disorders affecting bone mass.
The BMD Test interaction with the operator is through a touchscreen LCD panel and a membrane switch/indicator panel on the front of the device. BMD Test options are presented to the operator through messages on the touchscreen.
The x-ray system state and x-ray controls are presented to the operator via the membrane switch/indicator panel on the front of the device.
The Accudxa 2 is a Class II medical device and a Class II laser product.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Dual Energy X-ray Absorptiometry (DXA)
Anatomical Site
middle finger of the non-dominant hand
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Nonclinical Testing: The previous generation accuDEXA Model 7100 used a set of five calibration phantoms of known BMC and BMD value, plus a sixth Quality Control phantom supplied to customers for QC activities in the field. The calibration phantoms are intended to calibrate the device across its operating range of BMD values. The Accudxa 2 uses the same calibration phantom set to ensure that BMD readings obtained from the device are equivalent to those of the accuDEXA Model 7100.
The Accudxa 2 complies with applicable FDA and international standards pertaining to electrical, mechanical, EMC, and radiation safety of medical and / or laser devices.
Lone Oak Medical Technologies has demonstrated through its comparison of characteristics with the predicate devices and comparison of performance testing with the predicate devices that the Accudxa 2 Bone Densitometer is substantially equivalent to the predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K971735, K981124, K001429, K000162, K970224
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1170 Bone densitometer.
(a)
Identification. A bone densitometer is a device intended for medical purposes to measure bone density and mineral content by x-ray or gamma ray transmission measurements through the bone and adjacent tissues. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
APR 2 7 2012
510(k) Summary
| 510 (k) Submitter/Owner | Lone Oak Medical Technologies |
|---|---|
| 3805 Old Easton Road | |
| Doylestown, PA 18902 | |
| Phone: 215-230-7607 | |
| Fax: 215-230-7609 | |
| Contact Person | David Comley |
| Vice President | |
| 215-230-7607 | |
| Email: david@loneoakmedical.com | |
| Date Prepared | December 6, 2011 |
| Trade Name | Accudxa 2 Bone Densitometer |
| Common Name | Bone Densitometer |
| Classification Name | Bone Densitometer |
Predicate Devices:
| Company | Device name | Product Code | 510(k) |
|---|---|---|---|
| Schick | |||
| Technologies | accuDEXA Bone | ||
| Densitometer | KGI | K971735 | |
| K981124 | |||
| K001429 | |||
| Alara, Inc | Metriscan Bone | ||
| Density System | KGI | K000162 | |
| Lunar Corp | PIXI | KGI | K970224 |
1
Device Description:
The Accudxa 2 Model 7200 is a Dual Energy X-ray Absorptiometer (DXA) screening device. The device is intended to calculate an index of bone mineral density in the middle finger of the non-dominant hand. By changing the high voltage on the X-ray tube, two energies are produced. Each of the two settings produces an image of the finger and each image is analyzed using various algorithms to produce a value of bone mineral density (BMD) and bone mineral content (BMC). These values are compared with a normative database, vielding a t-score and a z-score. The t-score is the number of standard deviations that the patient is above or below the mean of a reference sample of young healthy individuals, which can be used by the physician as an aid to diagnose osteoporosis or osteopenia and to estimate fracture risk. The z-score is the number of standard deviations that the patient is above or below the mean of a reference sample of individuals of the same age as the patient, which can be used by the physician as an aid to diagnose other disorders affecting bone mass.
The BMD Test interaction with the operator is through a touchscreen LCD panel and a membrane switch/indicator panel on the front of the device. BMD Test options are presented to the operator through messages on the touchscreen.
The x-ray system state and x-ray controls are presented to the operator via the membrane switch/indicator panel on the front of the device.
The Accudxa 2 is a Class II medical device and a Class II laser product.
Indications for Use:
The Accudxa 2 is a dual-energy x-ray device indicated for use in estimating the bone density of the middle finger of the non-dominant hand (BMD). This BMD value is a relative indicator of bone density elsewhere in the body. Accudxa 2 BMD estimates, t-score and z-score can be used as an aid to the physician in determining fracture risk and for monitoring changes in bone mass over time.
Nonclinical Testing:
The previous generation accuDEXA Model 7100 used a set of five calibration phantoms of known BMC and BMD value, plus a sixth Quality Control phantom supplied to customers for QC activities in the field. The calibration phantoms are intended to calibrate the device across its operating range of BMD values. The Accudxa 2 uses the same calibration phantom set to ensure that BMD readings obtained from the device are equivalent to those of the accuDEXA Model 7100.
2
The Accudxa 2 complies with applicable FDA and international standards pertaining to electrical, mechanical, EMC, and radiation safety of medical and / or laser devices.
Technological Characteristic Comparison:
Lone Oak Medical Technologies purchased the accuDEXA Bone Densitometer design from Schick Technologies in August 2007. This design was repackaged and updated to reduce the size and weight of the unit. The same algorithms, normative database and sensor used in the Schick design (K971735, K981124, K001429) are used in the Lone Oak design. The software changes to the Schick design concern the Graphical User Interface, Operating System and communication protocol to the new hardware (touchscreen, memory, USB interface, controller board, etc.).
Conclusion:
Lone Oak Medical Technologies has demonstrated through its comparison of characteristics with the predicate devices and comparison of performance testing with the predicate devices that the Accudxa 2 Bone Densitometer is substantially equivalent to the predicate devices.
3
Image /page/3/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is an abstract image of an eagle with its wings spread.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
APR 2 7 2012
Mr. David Comley Vice President Lone Oak Medical Technologies 3805 Old Easton Road DOYLESTOWN PA 18902
Re: K113616
Trade/Device Name: accudxa2 Bone Mineral Densitometer Regulation Number: 21 CFR 892.1170 Regulation Name: Bone Densitometer Regulatory Class: II Product Code: KGI Dated: April 20, 2012 Received: April 23, 2012
Dear Mr. Comley:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of
4
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely Yours,
Janine M. Morris
Acting Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
5
Indications for Use Form
510(k) Number (if known): K113616
Device Name: accudxa2 Bone Mineral Densitometer
Indications for Use:
The Accudxa 2 is a dual-energy x-ray (DXA) device indicated for use in estimating the bone density of the middle finger of the non-dominant hand (BMD). This BMD value is a relative indicator of bone density elsewhere in the body. Accudxa 2 BMD estimates, t-score and z-score can be used as an aid to the physician in determining fracture risk and for monitoring changes in bone mass over time.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Division Sign-Off
Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) K113616
Page 4